A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy…
Show full title
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Agreed to (Senate)
Dec 14, 2023
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Dec 14, 2023
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
This resolution expresses the sense of the Senate that (1) policies governing access to medication abortion care should be based on scientific review by the Food and Drug Administration (FDA), and (2) the FDA has found mifepristone to be safe and effective for women seeking abortions.
What's happening now
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
36
D
Murray, Patty
D
Ossoff, Jon
D
Baldwin, Tammy
D
Bennet, Michael F.
D
Blumenthal, Richard
D
Booker, Cory A.
D
Cantwell, Maria
D
Cortez Masto, Catherine
D
Duckworth, Tammy
D
Durbin, Richard J.
D
Fetterman, John
D
Gillibrand, Kirsten E.
D
Hassan, Margaret Wood
D
Heinrich, Martin
D
Hickenlooper, John W.
D
Hirono, Mazie K.
D
Kelly, Mark
I
King, Angus S., Jr.
D
Klobuchar, Amy
D
Markey, Edward J.
D
Merkley, Jeff
D
Murphy, Christopher
D
Padilla, Alex
D
Reed, Jack
D
Rosen, Jacky
I
Sanders, Bernard
D
Schatz, Brian
D
Schumer, Charles E.
D
Shaheen, Jeanne
Sinema, Kyrsten
D
Smith, Tina
D
Van Hollen, Chris
D
Warnock, Raphael G.
D
Welch, Peter
D
Whitehouse, Sheldon
D
Wyden, Ron
Cite this page
U.S. Congress. (2026). S. Res. 510: A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.. 118th Congress. Open America. https://openamerica.io/bill/118-SRES-510/
"S. Res. 510: A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-SRES-510/.
S. Res. 510, 118th Cong. (2026), https://openamerica.io/bill/118-SRES-510/.
[S. Res. 510: A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.](https://openamerica.io/bill/118-SRES-510/)